United Therapeutics continues to underperform Gilead by 26.5% in the past month

Press/Media

Period3 Mar 2025

Media coverage

6

Media coverage

  • TitleUnited Therapeutics continues to underperform Gilead by 26.5% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to outperform Alnylam Pharmaceuticals by 0.2% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Amgen by 17.7% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics continues to underperform Regeneron by 12.7% in the past month
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Mettler-Toledo
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein
  • TitleUnited Therapeutics's Earnings Growth Lags Edwards Lifesciences
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date3/03/25
    PersonsJeffrey Klein